Charles River Laboratories (CRL) Tops Q2 EPS by 28c; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mail
Get Alerts CRL Hot Sheet
Price: $342.44 -4.72%
EPS Growth %: +22.2%
Financial Fact:
Provision (benefit) for income taxes: 15.57M
Today's EPS Names:
LTBR, AES, SYRS, More
EPS Growth %: +22.2%
Financial Fact:
Provision (benefit) for income taxes: 15.57M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q2 EPS of $3.02, $0.28 better than the analyst estimate of $2.74. Revenue for the quarter came in at $1 billion versus the consensus estimate of $976.13 million.
FY2026 Outlook-
EPS between $11.15 to $11.45 versus consensus $11.09.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Estee Lauder (EL) PT Raised to $129 at Goldman Sachs
- Morgan Stanley bearish on Coinbase, slashes target on weaker recovery
- IDEXX Laboratories (IDXX) PT Raised to $725 at Leerink
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
